- Home
- TCRX vs AMWL Comparison
TCRX vs AMWL Comparison
Compare TCRX & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- AMWL
- Stock Information
- Founded
- TCRX 2018
- AMWL 2006
- Country
- TCRX United States
- AMWL United States
- Employees
- TCRX N/A
- AMWL N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- AMWL Retail: Computer Software & Peripheral Equipment
- Sector
- TCRX Health Care
- AMWL Technology
- Exchange
- TCRX Nasdaq
- AMWL Nasdaq
- Market Cap
- TCRX 91.7M
- AMWL 106.7M
- IPO Year
- TCRX 2021
- AMWL 2020
- Fundamental
- Price
- TCRX $1.79
- AMWL $7.28
- Analyst Decision
- TCRX Strong Buy
- AMWL Hold
- Analyst Count
- TCRX 6
- AMWL 7
- Target Price
- TCRX $9.50
- AMWL $9.17
- AVG Volume (30 Days)
- TCRX 255.2K
- AMWL 78.9K
- Earning Date
- TCRX 08-12-2025
- AMWL 08-05-2025
- Dividend Yield
- TCRX N/A
- AMWL N/A
- EPS Growth
- TCRX N/A
- AMWL N/A
- EPS
- TCRX N/A
- AMWL N/A
- Revenue
- TCRX $6,961,000.00
- AMWL $269,783,000.00
- Revenue This Year
- TCRX $159.20
- AMWL $2.70
- Revenue Next Year
- TCRX N/A
- AMWL $7.06
- P/E Ratio
- TCRX N/A
- AMWL N/A
- Revenue Growth
- TCRX N/A
- AMWL 5.83
- 52 Week Low
- TCRX $1.02
- AMWL $6.10
- 52 Week High
- TCRX $6.23
- AMWL $12.95
- Technical
- Relative Strength Index (RSI)
- TCRX 54.34
- AMWL 45.00
- Support Level
- TCRX $1.60
- AMWL $7.04
- Resistance Level
- TCRX $1.86
- AMWL $7.46
- Average True Range (ATR)
- TCRX 0.10
- AMWL 0.55
- MACD
- TCRX 0.00
- AMWL -0.06
- Stochastic Oscillator
- TCRX 70.37
- AMWL 22.59
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About AMWL American Well Corporation
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.